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The presence of cerebral microbleeds (CMBs) has been dem-onstrated using magnetic resonance imaging (MRI) in the 
brains of patients with cardiovascular risk factors, cognitive 
deterioration, small vessel disease, and dementia.1 The most re-
liable MRI method for the detection of CMBs is susceptibility-
weighted imaging (SWI), owing to its sensitivity to the presence 
of iron-storage complex hemosiderin,2–4 which is deposited in 
abundance following hemorrhage.3 SWI imaging has been found 
to be almost 6× more sensitive to microhemorrhagic events 
than a conventional T2-weighted gradient-echo sequence.5
CMBs may occur in the presence of amyloid deposits in 
the walls of cerebral blood vessels (cerebral amyloid angi-
opathy [CAA]), as well as with chronic hypertension, diffuse 
traumatic axonal injury, and during critical illness, among 
other causes.6 CMBs consequently mark the presence of dif-
fuse vascular, traumatic, and neurodegenerative brain damage.
The results of recent studies investigating the role of 
CMBs in cognitive impairment have been inconsistent. The 
Rotterdam Scan Study reported that the presence of CMBs 
increases with age in 18% of people aged 60 to 69, and in 
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39% of those >80 years.7 Healthy subjects with CMBs showed 
reduced motor speed and information processing8 as well 
as shortened attention, indicating a worsening outcome as 
assessed by the Mini-Mental State Examination.9,10
A small case study reported gradient-echo–detected 
CMBs after cardiopulmonary bypass (CPB) in 6 children. All 
cases showed multiple microbleeds (>3 CMBs) situated in 
the cortical or lobar regions.11 Another study of 23 pediatric 
cardiac surgery patients receiving CPB reported the incidence 
of new CMBs postsurgery to be 90%.12 However, the preva-
lence, location, and frequency of CMBs in adult cardiac sur-
gery, in relation to perioperative factors and cognitive status, 
is unknown.
CPB has long been considered a major risk factor for neu-
rological injury after cardiac surgery. Injury to the brain after 
cardiac surgery is not restricted to hemorrhagic events but 
incorporates a range of neurological harmful effects including 
hypoxia, ischemia, and stroke.13,14 A study by Michałowska 
et al,15 reported SWI lesions in patients undergoing off-pump 
(n=36) and on-pump (n=15) cardiac surgery. The authors re-
ported that patients undergoing on-pump surgery had more 
SWI lesions compared with the off-pump group, though the 
comparison was not controlled for covariates such as age, sex, 
and perioperative risk factors.
Modern MRI techniques, such as SWI, enable confident 
identification of the number and spatial distribution of CMBs. 
This study aimed to estimate the burden of new CMBs in adult 
cardiac surgery patients relative to intraoperative factors and 
cognitive status. CMBs are not a rare observation in the aging 
population; therefore, it is necessary to assess whether phys-
iological stresses associated with cardiac surgery give rise to 
an additional burden of new CMBs and cognitive decline, and 
if so, what factors are associated with each of these outcomes.
Methods
Patients
The authors declare that all supporting data are available within 
the article (and in the online-only Data Supplement). All patients 
needing on-pump coronary artery bypass graft or valve surgery at 
Leicester Glenfield Hospital were eligible for inclusion in this study. 
Patients were excluded if they had contraindications to MRI (eg, a 
cardiac pacemaker), or if their first language was not English, be-
cause of the neuropsychological tests containing a language compo-
nent. Patient characteristics available for analysis as part of this study 
included age, sex, educational level, smoking status, hypertension, 
hypercholesterolemia, and ischemic heart disease. Written informed 
consent was provided by all patients following a protocol approved 
by the University Hospitals of Leicester NHS Trust and Derbyshire 
Research Ethics Committee (REC reference: 10/H0401/78). The 
study was sponsored by the University of Leicester.
Anesthetic and Surgical Procedures
All patients received routine perioperative care, and there were no 
explicit alterations to standard surgical practice. Cold crystalloid 
cardioplegia was used, and anesthetic management consisted of a 
combination of propofol, midazolam, isoflurane, and fentanyl. Body 
temperature was measured every 3 minutes with a nasal pharyngeal 
temperature probe. Nonpulsatile CPB was implemented with a non-
occlusive roller pump to achieve a target CPB perfusion pressure >50 
mm Hg. The CPB circuit contained a 38 μm arterial line filter and a 
membrane oxygenator. Arterial blood pressure targets during surgery 
were based on usual clinical practice.
Neuropsychological Assessment
Neuropsychological tests were performed 1 to 2 weeks before sur-
gery and 6 to 8 weeks postoperatively at the same time points as 
the MRI scans. Our test battery included 2 tests recommended by 
the Statement of Consensus on Assessment of Neurobehavioral 
Outcome after Cardiac Surgery16: the Grooved Pegboard Test17 and 
the Trail Making Tests (parts A and B).18 In addition, the Wechsler 
Abbreviated Scale of Intelligence19 and the Wechsler Memory Scale-
Third Edition20 were administered. Patients also completed a Hospital 
Anxiety and Depression Scale questionnaire.21 These tests were 
selected to allow pairwise comparison of before and after scores, 
as well as being accompanied by well-characterized normative data 
in age-matched healthy subjects (analyzed via z-score analysis). 
Neuropsychological assessments were performed by a trained asses-
sor who was blinded to the imaging data.
Magnetic Resonance Imaging
MRI was performed 1 to 2 weeks before surgery and 6 to 8 weeks 
postoperatively at the same time points as the neuropsycholog-
ical assessment. All MRI examinations were conducted using a 3T 
whole-body scanner (Magnetom Skyra; Siemens Medical, Erlangen, 
Germany). Scans were performed in the following order: 3-plane 
localizer; diffusion-weighted sequence; time of flight MR angiog-
raphy; SWI; and fluid-attenuated inversion recovery. For the SWI, the 
k-space matrix was 256×213 reconstructed to 256×224, field of view 
was 240 mm×210 mm, slice thickness was 3 mm, repetition time/
echo time were 1290/20 ms with a flip angle of 60 degrees. The total 
imaging time was ≈30 minutes. To distinguish new CMBs from old 
CMBs, SWI images were presented to a qualified neuroradiologist 
(A. Cox) who was blinded to the results of the neuropsychological 
assessments. Fluid-attenuated inversion recovery images were also 
presented for detection of new ischemic changes.
Identification of CMBs
SWI images were examined by a neuroradiologist using the Brain 
Observer Microbleed Rating Scale to aid identification and loca-
tion of CMBs.22 CMBs were identified as defined focal areas of low 
signal on SWI, <10 mm in diameter. Symmetrical areas of basal 
ganglia calcification, flow voids from blood vessels, and low signal 
from adjacent bone were excluded. New CMBs were then charac-
terized through registration and subtraction of pre- and postoper-
ative SWI images using the medical image analysis package Jim 
(version 7, Xinapse Systems, Colchester, United Kingdom; http://
www.xinapse.com; Figure 1).23 Images were assessed for the loca-
tion and number of both new and preexisting CMBs, which were 
delineated using a semiautomatic contouring technique. To aid visu-
alization of the distribution of new CMBs, postoperative SWI images 
were registered to a standard MRI brain atlas,24 and new CMBs were 
segmented and displayed using the atlas as reference for the 3-dimen-
sional (3D) display.
Identification of CAA
Probable CAA was characterized by the neuroradiologist using 
the Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the 
Boston Criteria.25 Information was sourced from clinical data, and 
MRI is demonstrating multiple hemorrhages (intracerebral hemor-
rhages, CMBs) restricted to cortical, lobar, or cortical/sub-cortical 
regions (including cerebellar hemorrhage), or single lobar, cortical, 
or cortical/subcortical hemorrhage and superficial siderosis (focal or 
disseminated).
Statistical Analysis
Data are presented as mean [±SD] unless stated otherwise. Statistical 
analyses were performed using the SPSS software package (Statistical 
Product and Service Solutions, SPSS, version 25; SPSS Inc). Tests 
for normality were performed using the Kolmogorov-Smirnov test. 
Differences with a P value of <0.05 were considered to be statistically 
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significant. Clinical demographic variables between patients with and 
without new CMBs were compared using Fisher test, a t test, or χ2 
test as appropriate. Interactions between cognitive status and the pres-
ence or absence of CMBs were examined using ANCOVA. Before 
data analysis, checks for any outliers of abnormities were performed. 
Two separate binomial logistic regression models were fitted for each 
perioperative variable which included the age of the patient, sex, hy-
pertension, CPB hematocrit levels, CPB time, mean arterial pressure, 
and the number of new CMBs. Model outputs are reported with their 
corresponding odds ratios, the 95% CIs for the odds ratio, and associ-
ated P values. Where applicable, variables were adjusted for age, sex, 
and educational level.
Individual neuropsychological test scores were converted to z 
scores through comparison with published data describing the mean 
(X) and SD of test scores measured from a population of healthy 
subjects:
z
x X
SD
=
−
 (1)
Postoperative z scores were then subtracted from preoperative z 
scores to calculate the pairwise change in z score; a significant decline 
in cognition was assumed if there was a drop in z score of >1 SD from 
baseline. For timed tests (Trail Making A/B and Grooved Pegboard 
tests), the sign of the z score was reversed, such that poorer perfor-
mance corresponded to a negative z score. In addition to calculating 
the z score change for each individual test, z scores were summed 
and averaged to quantify the overall cognitive performance of each 
patient as a composite cognitive performance score.26
Results
Of the 103 patients recruited in the study, 20 did not receive 
a preoperative MRI scan because of scheduling difficulties, 
4 were unable to receive a postoperative scan (fitted pace-
maker), and 4 withdrew from the study. Complete pre- and 
postoperative MRI and cognitive test data were analyzed 
from the remaining 75 patients (70 men; 63±10 years). 
Diffusion-weighted images were also examined alongside 
SWI images. Because diffusion-weighted imaging is sensi-
tive only to acute ischemic lesions, the length of time from 
surgery to the postoperative MRI scan precluded any conclu-
sions being drawn about the relationship between periopera-
tive ischemia and new CMBs. A table summarizing all data 
relating to this study is provided in Tables I and II in the 
online-only Data Supplement.
After surgery, new CMBs were identified using SWI MRI 
in 76% (57/75) of patients. Fourteen patients (24%) had at 
least 1 new CMB, 26 patients (46%) had 2 to 5 new CMBs, 
and 17 patients (30%) had >5 new CMBs. The highest re-
ported number of new CMBs was observed in patient 38 who 
had 43 new CMBs. The CPB time for this patient was 254 
minutes compared with the cohort average of 90 minutes: SD, 
49 (full details for all patients can be found in Tables I and II 
in the online-only Data Supplement). The prevalence of pre-
existing CMBs was small in comparison to new CMBs. In this 
cohort, 36% (27/75) had preexisting CMBs, of which 67% 
(18/27) had only 1 preexisting microbleed, 22% (6/27) had 2 
to 3 preexisting CMBs, and 11% (3/27) had 6 to 7 preexisting 
CMBs. All preexisting CMBs were observed in the postoper-
ative SWI scans.
Comparison between the groups with and without new 
CMBs showed significant differences in the new CMBs group 
for type of procedure (coronary artery bypass graft versus 
valve; χ2 test, P=0.007), and CPB time (97 versus 68 min-
utes; t test, P=0.003). There were borderline associations 
with lower hematocrit (mean hematocrit: 27% versus 30%; t 
test, P=0.045), and number of preexisting CMBs (0.82 versus 
0.32; t test, P=0.021; Table 1). All 9 patients with CAA had 
new CMBs postcardiac surgery (Table 1). The volume of new 
ischemic lesions after cardiac surgery was also significantly 
higher in patients with new CMBs (82 versus 11 cm3; t test, 
P=0.032).
A 3D illustration of the overall distribution of new CMBs, 
from the 57 patients with changes after cardiac surgery, is 
presented in Figure 2. New CMBs after cardiac surgery in 
Figure 1. Comparison of susceptibility-
weighted imaging images before and after 
cardiac surgery. Registration and subtraction of 
the magnetic resonance imaging data were per-
formed using JIM software (Xinapse Ltd) to con-
fidently distinguish new cerebral microbleeds 
(CMBs) from preexisting CMBs, providing the 
number and location of CMBs.
D
ow
nloaded from
 http://ahajournals.org by on January 30, 2019
Patel et al  Cerebral Microbleeds After Cardiac Surgery  339
patients with cognitive decline are shown in red and without 
cognitive decline in green. The majority of new CMBs were 
located in the frontal lobe (46%) followed by the parietal lobe 
(15%), cerebellum (13%), occipital lobe (12%), temporal 
lobe (8%), hippocampal (1.4%), putamen/globus pallidus 
(1.4%), thalamus (1%), and the midbrain (1%). A detailed 
presentation of the location and distribution of new CMBs 
after surgery is provided in Table III in the online-only Data 
Supplement.
A decline in neuropsychological test performance of >1 
SD after surgery in ≥1 tests was noted in 33 (44%) of 75 
patients. Five patients (15%) declined in >2 tests. Cognitive 
regions for decline were associated with psychomotor func-
tion (54% [18]), executive function (39% [13]), working 
memory (18% [6]), and long-term memory (9% [3]). Most 
patients had typical levels of depression and mild levels of 
anxiety on the Hospital Anxiety and Depression Scale at pre-
operative testing (mean [SD]; anxiety, 6.1 [3.6]; depression, 
3.8 [3.0]), which were stable or reduced after surgery (anxiety, 
3.8 [2.5]; depression, 2.8 [3.1]). Decline in neuropsycholog-
ical performance was therefore not attributable to heightened 
anxiety or depression.
The 4 major neuropsychological domains (executive 
function, psychomotor function, working memory, and 
long-term memory) were studied in relation to the devel-
opment of new CMBs. Adjusted z scores were lower for 
all 4 cognitive domains in the group of patients with new 
CMBs; however, there were no significant differences be-
tween subjects with and without CMBs after controlling for 
age and sex (Table 2). The greatest decline in mean post-
operative z scores between groups with and without new 
CMBs were observed in executive function tasks (mean 
[SD]: −0.03 [0.10] versus 0.21 [0.19], ANCOVA, P=0.24) 
and psychomotor function (0.02 [0.07] versus 0.26 [0.19], 
ANCOVA, P=0.07). The number of new CMBs were sepa-
rated into 3 groups: (i) 1 CMB, (ii) 2 to 5 CMBs, and (iii) 
>5 CMBs (Figure 3). Marginal decreases in average z scores 
with increasing number of CMBs were noted for working 
memory, executive function, and long-term memory, but 
given the wide variations observed in our cohort, these did 
not prove to be statistically significant (Table 2). Our anal-
ysis did not provide evidence for a trend between multiple 
new CMBs and declining neuropsychological test scores in 
any of the domains tested.
The contribution of various perioperative risk factors 
during cardiac surgery against the outcome of new CMBs 
and neuropsychological impairment was explored using 
2 separate logistic regression models with outcomes of 
(i) new microbleeds and (ii) neuropsychological decline. 
Covariates for the model included age, sex, CPB time, hy-
pertension, mean arterial pressure, hematocrit, and number 
of new CMBs. CPB time was the only significant predictor 
for new CMBs during cardiac surgery (1.02; 95% CI, 1.00–
1.05; P=0.04) suggesting a ≈2% increase in the odds of 
acquiring new CMBs for every minute of bypass time over 
80 mins (Table 3). Age was the only significant predictor 
of cognitive impairment postcardiac surgery (1.07; 95% 
CI, 1.01–1.13; P=0.01), with the risk of cognitive decline 
increasing by ≈7% per year of age over 63 years (Table 3). 
While hypertension and mean arterial pressure were also 
investigated, there was no significant association of blood 
pressure parameters with new CMBs (Table 3).
Discussion
SWI is a powerful MRI sequence that is almost 6× more 
sensitive to microhemorrhagic events than conventional 
T2-weighted gradient-echo.4 SWI’s higher sensitivity to lev-
els of hemosiderin, an iron-storage complex found in abun-
dance after hemorrhagic events2–4 allows for better detection 
of CMBs.
Comparison With Pediatric Studies
In this present study, 76% of patients had new CMBs after car-
diac surgery with 51% having multiple CMBs. The prevalence 
of new CMBs after heart surgery in adults was lower than pre-
viously reported after pediatric surgery. The study by Kim 
et al12 investigated CMBs using SWI in 23 pediatric patients 
with heart failure who underwent surgery using CPB, against 
13 pediatric patients with no CPB (ie, no surgery). The authors 
reported significantly higher numbers of CMBs in the surgical 
Table 1. Clinical and Demographic Characteristics of Patients With and Without 
New CMBs After Cardiac Surgery
 
New 
Microbleeds 
Present 
(n=57)
New 
Microbleeds 
Absent 
(n=18) P Value
Men:women 16:2 54:3 0.588*
Age, y (mean±SD) 63±9 61±15 0.598†
CABG:valve 15:42 11:7 0.007‡
CPB time, min (mean±SD) 97±53 68±25 0.003†
Mean arterial blood pressure, 
mm Hg (mean±SD)
62±9 63±8 0.603†
Mean hematocrit, % (mean±SD) 27±9 30±3 0.045†
Smoking, n (%) 28 (49) 9 (50) 0.984‡
Treated hypertension, n (%) 39 (68) 15 (83) 0.219‡
Hypercholesterolemia, n (%) 40 (71) 16 (89) 0.133*
Ischemic heart disease, n (%) 29 (51) 12 (67) 0.241‡
Aortic stenosis (mild/severe), n (%) 31 (54) 10 (55) 0.931‡
Preexisting WMD, mm3 (mean±SD) 2225±6488 1359±2720 0.418†
Volume of new ischemic damage, 
mm3 (mean±SD)
82±241 11±21 0.032†
No. of old CMBs, n (mean±SD) 0.82±1.5 0.28±0.4 0.021†
Post-op stroke, n (%) 5 (9) 0 (0) 0.329*
Probable CAA, n (%) 9 (16) 0 (0) 0.103*
Neuropsychological decline, n (%) 25 (44) 8 (44) 0.965‡
Values reported are mean (SD) or count (%) or in a ratio format. CAA indicates 
cerebral amyloid angiopathy; CABG, coronary artery bypass grafting; CMB, 
cerebral microbleeds; CPB, cardiopulmonary bypass; and WMD, white matter 
disease.
*Fisher exact test.
†t test.
‡χ2 test.
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group compared with the nonsurgery group (P<0.001). The 
authors concluded that exposure to CPB increases the prev-
alence and burden of CMBs among pediatric patients with 
heart failure.
CPB Machine
There are several perioperative risk factors associated with 
neurological damage during cardiac surgery.27 CPB time 
tends to increase with complexity of the surgery and has 
previously been linked to neurological complications such 
as acute encephalopathy, stroke, and cognitive decline.8,10 
During CPB, air emboli can also be introduced into the CPB 
circuit, detected using transcranial Doppler ultrasound.28 
Our logistic regression model suggests that the length of 
CPB time may be a significant predictor for the develop-
ment of new CMBs after cardiac surgery (odds ratio, 1.02; 
95% CI, 1.00–1.05; P=0.04). This implies an increase in the 
odds of acquiring new CMBs of between 0% and 5% for 
every minute of bypass time over 80 mins. Although the P 
value is borderline and the CI includes 1, even a very small 
increase in risk associated with increased bypass time, when 
measured on a minute-by-minute basis, has the potential to 
accumulate significantly over the course of surgery. New 
CMBs were therefore associated with significantly longer 
CPB times (P=0.003; Table 1).
Figure 2. The spatial distribution of new cerebral microbleeds (CMBs) after cardiac surgery, compiled from the combined data of 57 patients with (green) and 
without (red) postoperative cognitive decline. Microbleeds are highlighted against the background of a standard atlas image. A, Superior, (B) coronal view, 
and (C) lateral view. D, Radar plot showing the distribution of new CMBs (blue line); number of patients with new CMBs in this region (red line); and total per-
centage distribution of new CMBs per brain region.
Table 2. Comparison of Cognition in Cases With and Without New CMBs After 
Cardiac Surgery
Cognitive Domain
New 
Microbleeds 
Present
New 
Microbleeds 
Absent F Test
(n=57) (n=18) P Value
Executive function −0.03 (0.10) 0.21 (0.19) 0.24
Psychomotor function 0.02 (0.07) 0.26 (0.19) 0.07
Working memory 0.11 (0.07) 0.25 (0.12) 0.30
Long-term memory 0.26 (0.11) 0.28 (0.19) 0.94
P values reported for the CMB group effect from a univariate ANCOVA 
controlling for effects of age and sex. Index scores expressed in units of normative 
SDs. Values represent mean (SD). CMB indicates cerebral microbleeds.
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Cognitive Outcome
Previous trials that have related CMBs to cognition in a stroke 
population and in normal aging have produced conflicting 
results. The majority of studies in healthy aging populations 
reported an association between neuropsychological outcome 
and CMBs.9,10 Studies of patients with symptomatic cere-
brovascular disease and CMBs have yielded less consistent 
results.29,30 A study by Patel et al30 looked at the relationship be-
tween CMBs and neurocognitive performance in a small vessel 
disease cohort. Another study by Pettersen et al31 looked at neu-
rocognitive performance and CMBs in patients with Alzheimer 
disease. The authors of both studies were unable to find a link 
between neuropsychological performance and CMBs.
The location of CMBs may be more significant than the 
number of CMBs in predicting neuropsychological sequelae. 
In the study by Pettersen et al,31 stroke patients with a decline 
in executive function had more CMBs in the basal ganglia 
compared with a control group. However, in a normal aging 
cohort, thalamic CMBs were linked with worse coordina-
tion on the Mini-Mental State Examination, which suggests 
a decline in executive function and visuospatial abilities.9 In 
a large cohort of patients with cerebral small vessel disease, 
neuropsychological deficits were associated with CMBs in the 
frontal and temporal lobes,29 whereas another study showed 
that the number of basal ganglia, thalamic, and frontal CMBs 
did not predict cognitive deficits after controlling for other 
MRI parameters.30 A recent study by Xiong et al32 studied 
CMBs and their association with cognition in patients with 
CAA. The authors found the presence of CMBs to be asso-
ciated with impaired executive function (P=0.036) and pro-
cessing speed (P=0.020); however, no significant difference 
was observed in global neuropsychological performance in 
patients with and without CMBs. Although we report neuro-
cognitive decline in 46% of our patients postcardiac surgery, 
this did not seem to be related to the observed number of new 
perioperative CMBs.
Probable CAA Diagnosis and New CMBs
CAA is characterized by extracellular deposition of 
amyloid-β around cerebral arteries and capillaries, leading 
Figure 3. Age, sex, and educational level adjusted average z scores are presented for cognitive outcomes in specific domains: (A) motor function, (B) working 
memory, (C) executive function, and (D) long-term memory. Patients were grouped by cerebral microbleed (CMB) count (0 CMBs, n=18; 1 CMBs, n=14; 2–5 
CMBs, n=26; >5 CMBs, n=17) to calculate the average z score of the group. Error bars represent 95% CIs on the mean.
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to an increased risk of neurological damage, such as hemor-
rhagic events (lobar and subarachnoid).25 This is a condition 
of increasing clinical and mechanistic importance, as patients 
with sporadic CAA have a higher mortality and are at risk of 
recurrent hemorrhage.33 The recent study by Xiong et al32 also 
found that the presence of CMBs predicted dementia conver-
sion in patients with CAA. The risk of damage to the vas-
culature because of the CPB machine during cardiac surgery 
may predispose some patients to receive new CMBs. Using 
the Evolution of the Boston Criteria for Diagnosis of Cerebral 
Amyloid Angiopathy,25 the neuroradiologist diagnosed a total 
of 9 patients with probable CAA. All 9 patients were reported 
to have developed new CMBs after cardiac surgery. Although 
the subpopulation of CAA in our sample was small (12%), 
this illustrates the vulnerability of patients with probable CAA 
to cerebral hemorrhagic damage when undergoing cardiac 
surgery. Further studies with a larger sample population of 
patients with CAA should be performed to elucidate the risk 
of cerebral vascular damage in this subgroup of patients when 
undergoing cardiac surgery.
Hematocrit and New CMBs
Mean [SD] hematocrit levels during CPB for all 75 patients 
in this study was 28% [3.9]. Previous studies have reported 
that hematocrit levels that drop below 22% may be a risk fac-
tor for perioperative neurological damage.14 To the best of our 
knowledge, this is the first study to report hematocrit levels 
in relation to new CMBs during cardiac surgery. In this co-
hort, patients with new CMBs had slightly lower hematocrit 
level (27%) compared with the group of patients with no new 
CMBs (30%; t test, P=0.04). The volume fraction of red blood 
cells in a capillary affects the degree to which platelets are pro-
moted to marginate to near a vessel wall to allow the forma-
tion of blood clots.34 Previously, an in vitro study investigating 
the relationship between red blood cell hematocrit levels and 
platelet adhesion activity was performed. This involved pass-
ing flowing blood through a microfluidic channel coated with 
type 1 collagen to determine the rate to which platelets adhered 
to the wall. The study reported that the rate of platelet adhe-
sion differs significantly with hematocrit levels, with a rela-
tive decrease in platelet activity as hematocrit levels fall.34 In 
this study, we observed a slightly lower hematocrit in patients 
with new CMBs (t test, P=0.04). Our logistic regression model 
suggested a relationship between hematocrit levels and new 
CMBs of borderline significance (odds ratio, 0.86; 95% CI, 
0.74–1.01; P=0.06), estimating that a 1 % increase in hemat-
ocrit above 28% reduces the risk of CMBs by ≈14%. A larger 
sample size would be required to confirm this finding.
Limitations
The use of anticoagulation/antithrombotic therapy may have 
played an important role in the observed results and may have 
been useful as a predictor of new CMBs. Unfortunately, in this 
study, these data were not recorded. This would be of signifi-
cant interest in future trials. Furthermore, this study would be 
strengthened with one or more additional neuroradiologists to 
read the MRI scans so that interreader variability for new and 
existing CMBs could be reported.
Conclusions
This study confirmed that CMBs and cognitive decline are 
common after cardiac surgery; 76% of patients had new CMBs, 
and 44% experienced cognitive decline. The presence of new 
CMBs postcardiac surgery is high in comparison to preexisting 
CMBs with a 7.6-fold increase in CMBs postcardiac surgery. 
Length of CPB time was a significant predictor of new CMBs. 
Levels of hematocrit were significantly lower in patients with 
new CMBs and patients with preexisting CMBs were more 
likely to have new CMBs after cardiac surgery. The presence of 
new CMBs was not found to be related to neuropsychological 
impairment, although some trends were observed that should 
be investigated in a larger study. Longitudinal studies may pro-
vide more robust information about whether CMBs are indeed 
markers of future cognitive decline. Studying a larger popu-
lation would also allow the relationship between hematocrit 
levels and new CMBs to be further investigated.
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